The ROE as of December 2025 (TTM) for TG Therapeutics, Inc. (TGTX) is 26.05%

According to TG Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 26.05%. This represents a change of 319.52% compared to the average of 6.21% of the last 4 quarters.

TG Therapeutics, Inc. (TGTX) Historical ROE (quarterly & annually)

How has TGTX ROE performed in the past?

The mean historical ROE of TG Therapeutics, Inc. over the last ten years is -167.48%. The current 26.05% ROE has changed -115.56% with respect to the historical average. Over the past ten years (40 quarters), TGTX's ROE was at its highest in in the March 2020 quarter at 3.78%. The ROE was at its lowest in in the June 2019 quarter at -274.24%.

TG Therapeutics, Inc. (TGTX) ROE by Quarter and Year

Discovering the peaks and valleys of TG Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TG Therapeutics, Inc. (TGTX) Average ROE

How has TGTX ROE performed in the past?

The current ROE of TG Therapeutics, Inc. (TGTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

TG Therapeutics, Inc. (TGTX) ROE vs. Peers

How is TGTX’s ROE compared to its peers?

TG Therapeutics, Inc.’s ROE is greater than PTC Therapeutics, Inc. (-182.66%), greater than Arrowhead Pharmaceuticals, Inc. (-41.19%), less than Protagonist Therapeutics, Inc. (6.86%), less than Krystal Biotech, Inc. (19.36%), greater than CRISPR Therapeutics AG (-25.25%), greater than Vaxcyte, Inc. (-21.08%), less than Alkermes plc (21.40%), greater than Arcellx, Inc. (-43.04%), greater than Immunovant, Inc. (-84.94%), greater than Kymera Therapeutics, Inc. (-33.35%),

Build a custom stock screener for TG Therapeutics, Inc. (TGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TG Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TG Therapeutics, Inc. (TGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TG Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.